세계의 임상용 차세대 시퀀싱(NGS) 분야 분석(2024-2030년)

Continued Investment in AI is Driving Transformational Growth by Accelerating Information Solutions Development

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. The NGS market encompasses end-to-end workflows, including library preparation, sequencing, and data analysis and interpretation, specifically designed for clinical applications across key end-user segments: pharmaceutical and biotechnology, and diagnostics. Within these sectors, NGS technologies are primarily employed to diagnose and monitor diseases, as well as for companion diagnostics, clinical trials, and patient stratification.

This analysis assesses the factors driving and restraining the growth of the use of NGS technology in clinical settings and offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities that the industry presents by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts.

Table of Contents

Ecosystem

• Scope of Analysis
• Segmentation

Growth Environment: Transformation in Clinical Next-generation Sequencing

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Clinical Next-generation Sequencing Industry

Ecosystem in Clinical Next-generation Sequencing

• Competitive Environment
• Key Competitors

Growth Generator in Clinical Next-generation Sequencing

• Growth Metrics
• Growth Drivers
• Growth Restraints
• Forecast Considerations
• Revenue Forecast
• Revenue Forecast by Product
• Revenue Forecast by Workflow
• Revenue Forecast by Application
• Revenue Forecast by Region
• Revenue Forecast Analysis
• Pricing Trends and Forecast Analysis
• Revenue Share
• Revenue Share Analysis
• Competitive Players
• Company Informatics Solutions for Applications

Growth GeneratorInstruments

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth GeneratorWorkflow Solutions

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth GeneratorServices

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth GeneratorInformatics

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Universe Analysis of the Clinical Next-generation Sequencing Sector

• Growth Opportunity 1: Integration of Multi-omics Data for Personalized Medicine
• Growth Opportunity 2: Minimal Residual Disease Detection and Treatment in Cancer
• Growth Opportunity 3: Expansion of Single-cell and Spatial Omics in Clinical Research
• Growth Opportunity 4: Genomics Initiatives and Bioinformatics Development in APAC and MEASA

Appendix & Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• List of Exhibits
• Legal Disclaimer